South Dakota Consumers Urged to Claim Compensation in Generic Drug Price Settlement

South Dakota Consumers Urged to Claim Compensation for Inflated Generic Drug Prices

South Dakota Attorney General Marty Jackley is urging consumers who purchased specific generic medications between May 2009 and December 2019 to check their eligibility and file claims for compensation following a multi-state antitrust settlement.

A Decade-Long Price-Fixing Conspiracy Unravels

For years, individuals purchasing essential generic medications across South Dakota unknowingly absorbed the costs of an illegal price-fixing conspiracy. The U.S. District Court for the District of Connecticut granted preliminary approval to a distribution plan designed to return settlement funds collected from generic drug manufacturers. These companies faced mounting legal pressure over allegations that they systematically conspired to inflate prices.

South Dakota Attorney General Marty Jackley has taken a firm stance against the corporate misconduct. “I will not allow South Dakota consumers to pay inflated prices for generic drugs,” Jackley stated. “Generic drug companies cannot be allowed to profit through illegally raised prices.”

The Multi-State Coalition and Settlement Figures

South Dakota is far from alone in this fight. The state sits within a massive coalition of nearly all U.S. states and territories that initiated a sweeping series of antitrust lawsuits against pharmaceutical manufacturers starting in 2016. To date, announced settlements within these coordinated legal actions have totaled $96.5 million.

The vast geographic footprint of this legal coalition highlights the national scale of the pricing scandal. Participating jurisdictions stretch from Alaska and Arizona to Wyoming, encompassing major states like California, New York, and Florida. For local consumers, this cooperation means that individuals who bought covered medications within the window of May 2009 to December 2019 may finally see financial relief.

How Consumers Can Check Eligibility and File Claims

Determining whether a specific prescription purchase qualifies for a payout requires checking a curated list of affected medications. The South Dakota Attorney General’s Office directs residents to review the official database hosted at aggenericdrugs.com to cross-reference their past purchases.

Consumers seeking assistance or wishing to verify their status can contact the administrators directly. Toll-free phone support is available at 1-866-290-0182, or inquiries can be sent via email to [email protected]. With preliminary court approval now secured, officials encourage eligible residents to act promptly and submit their claims before the distribution process moves forward.

Jurisdictions Involved in the Antitrust Coalition

The immense scope of the litigation is reflected in the roster of participating states and territories. Alongside South Dakota, the coalition includes:

Photo: brookingsradio.com

• Alaska, Arizona, California, Colorado, Connecticut, and Delaware
• District of Columbia, Florida, Georgia, Idaho, Illinois, and Indiana
• Iowa, Kansas, Kentucky, Maine, Maryland, and Massachusetts
• Michigan, Minnesota, Mississippi, Montana, Nebraska, and Nevada
• New Hampshire, New Jersey, New Mexico, New York, North Carolina, and North Dakota
• Northern Mariana Islands, Ohio, Oklahoma, Oregon, Pennsylvania, and Puerto Rico
• Virgin Islands, and Utah
• Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming

As the claims administration process rolls out across these regions, Americans who relied on affordable generic medications are being given a formal avenue to recover funds lost to corporate price inflation.